We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App





Rober Showcases Pioneering ‘Zero Pressure’ Mattresses in Germany

By HospiMedica International staff writers
Posted on 14 Nov 2018
Rober Ltd. More...
(Chesterfield, UK), a company that specializes in the development and manufacture of ‘zero pressure’ technology, showcased its full range of pioneering mattress solutions at MEDICA 2018.

Rober has developed a complete range of pressure ulcer mattresses catering to a variety of needs, including patients who are immobile, bariatric or have existing pressure injuries. All Rober’s mattresses are developed in conjunction with clinicians and feature clinically proven technology, which prevents pressure injuries from developing. The mattresses also have therapeutic properties, which promote the healing of established ulcers. The mattresses are fully automatic, and patients nursed upon them require less frequent manual repositioning, thus relieving the pressure on busy nursing staff. They can be used in everyday nursing environments, as well as acute care facilities.

For instance, the company’s new mattress, NoDec AIRSTREAM THP (Total Heel Protection) is designed specifically to relieve pressure on the heel and lower limbs and contains an independent heel zone that prevents pressure ulcers from occurring at this site as well as helps heal existing pressure injuries. At MEDICA 2018, Rober also showcased its intensive care pressure ulcer mattress specially designed to offer pressure ulcer relief to immobile and critically ill patients. For instance, Rober’s WIZARD mattress combines the company’s signature alternating pressure cell design with an impressive tilt facility which gently turns the patient onto their side, comfortably and correctly.

“Designed and manufactured in the UK, Rober’s mattresses and overlays have been developed to replicate the body’s natural movements by responding to a patient’s weight, spontaneous movement pattern and body position. They provide enhanced comfort and complete pressure elimination at regular intervals,” said Mike Hutson, Chief Executive of Rober.

Related Links:
Rober


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasonic Dissector
SONICBEAT
New
MR Trolley
MR9002
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: Researchers have taken a major step toward cuff-free blood pressure monitoring (Photo courtesy of Gwyneth Moe/Boston University)

Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension

Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.